High blood pressure is a widespread issue affecting countless individuals. The standard solution has been to take medication daily.
However, more than half of the people with high blood pressure forget to take their pills regularly, complicating efforts to manage the condition.
This oversight is concerning, as uncontrolled high blood pressure can lead to serious health problems such as strokes, heart attacks, and even premature death. Therefore, finding an easier way to control high blood pressure is crucial.
Enter zilebesiran, a promising new medication currently under research that could revolutionize how high blood pressure is treated.
Developed through collaboration including the University of Edinburgh, this drug could significantly lower blood pressure for up to six months with just a single injection.
In trials conducted in the UK, participants who received zilebesiran experienced a substantial decrease in their systolic blood pressure. This measurement indicates the pressure in the arteries when the heart beats.
For those receiving doses of 200mg or higher, the reduction in systolic blood pressure averaged over 10 mmHg.
Remarkably, a dose of 800mg resulted in a reduction of more than 20 mmHg, potentially bringing individuals’ blood pressure within a healthier range.
Zilebesiran, crafted by the American company Alnylam Pharmaceuticals, operates by inhibiting the production of angiotensin, a hormone that narrows blood vessels and elevates blood pressure.
It targets the liver, preventing the production of angiotensinogen, the precursor protein for angiotensin.
The drug employs a sophisticated technique to deactivate the gene responsible for producing angiotensinogen, effectively halting the hormone’s production.
The initial study involved 107 participants diagnosed with high blood pressure. Eighty received the drug, while the remainder were given a placebo.
The encouraging outcomes have led researchers to plan further studies to confirm zilebesiran’s safety and to explore its long-term effects on managing high blood pressure.
Professor David Webb from the University of Edinburgh highlighted the significance of this development, noting that it has been 17 years since a new type of high blood pressure medication was introduced.
Zilebesiran’s novel approach could simplify treatment adherence for patients. The focus is now on ensuring the drug’s safety and efficacy before it can be made available for wider use.
Zilebesiran represents a potential breakthrough in the treatment of high blood pressure, offering a more convenient solution for those struggling to maintain their medication regimen.
As research continues, this drug could become a viable and straightforward option for many people.
For individuals concerned about high blood pressure, exploring unrecognized causes and adopting beneficial habits can also be helpful.
Recent studies offer insights into effective treatment strategies and how dietary choices, such as potato consumption, may influence blood pressure levels.
The research findings on zilebesiran were published in the New England Journal of Medicine, marking a significant advance in the quest for better high blood pressure management solutions.
If you care about blood pressure, please read studies about how diets could help lower high blood pressure, and 3 grams of omega-3s a day keep high blood pressure at bay.
For more information about health, please see recent studies that beetroot juice could help reduce blood pressure, and results showing cinnamon could help lower high blood pressure.
Copyright © 2024 Knowridge Science Report. All rights reserved.
